|
|
Dysglycaemia in Non-Diabetic Individual from South Asians,
|
|
|
|
|
نویسنده
|
Aarabi M ,Jackson PR
|
منبع
|
iranian journal of public health - 2005 - دوره : supp - - کد همایش: - صفحه:10
|
چکیده
|
South asian people in the united kingdom have a higher risk of having coronary heart disease (chd) and stroke than the general population. haemoglobin ale (hbalc) is a specific type of glycosylated haemoglobin that strongly correlates with the level of ambient glycaemia during a 2-3 month period. it is not clear whether differences in traditional chd risk factors alone fully explain the increased risk in south asians. we aimed to compare hbalc level in uk south asians and caucasians.methods: data from health survey for england 1999 were employed to study ethnic differences in fasting blood glucose and hbalc. 535 south asian 425 caucasian aged 35-69 years with no history of cardiovascular diseases, taking lipid lowering medication, or diabetes, and with fasting blood glucose < 7.8 mmol/1 (140 mg/100) were included in the analysis. results: the hbalc levels ranged from 4.3-7.7% in south asians and 4.5-6.7% in caucasians. its level correlated with fasting blood glucose in both south asians and caucasians, r = 0.36 (p< 0.001) and r = 0.28 (p< 0.001) respectively. the distribution of hbalc in south asians was shifted to the right as compared with that of caucasians. caucasians had proportionately more hbalc values in quartiles i and ii of the total population, whilst 50.3% of south asians were in the third and fourth quartiles compared to 29.9% of caucasian participants. conclusions: the difference in risk of chd between non-diabetic south asian and caucasians is not explained by differences in the impact of the traditional risk factors. part may be due to higher blood sugar concentrations in non-diabetic south asians.
|
کلیدواژه
|
Coronary heart disease ,South Asian ,Blood glucose ,Ethnicity ,Glycosylated haemoglobin (HbA)
|
آدرس
|
golestan university of medical sciences, Royal Hallamshire Hospital, Dept of Health, ایران, University of Sheffield, Royal Hallamshire Hospital, Clinical Pharmacology, UK
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|